https://www.selleckchem.com/products/dcz0415.html
In the study comparing lorazepam to olanzapine, olanzapine was superior to lorazepam, and both were superior to placebo. As expected, the safety of lorazepam among the different studies was consistent with its well-characterized profile with dizziness, sedation, and somnolence being the most common adverse events. Based on this structured review, lorazepam can be considered to be a clinically effective means of treating the acutely agitated patient.Background Less than 20% of people with addictions have access to adequate treatment. Mob
Like
Comment
Share
